Anti-tumor agent comprising cytidine derivative and carboplatin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8586561
APP PUB NO 20110118205A1
SERIAL NO

12934772

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAIHO PHARMACEUTICAL CO LTDCHIYODA-KU TOKYO 101-8444
SASAKI TAKUMA101-1-2-404 YAGOTOFUJIMI SHOWA-KU NAGOYA-SHI AICHI 466-0812
MATSUDA AKIRA1-7-501 KITA 24 JOU NISHI 12-CHOME KITA-KU SAPPORO-SHI HOKKAIDO 001-0024

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kazuno, Hiromi Hanno, JP 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 19, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00